BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31046901)

  • 1. Contraceptive efficacy and dose-response effects of the gonadotrophin-releasing hormone (GnRH) agonist deslorelin in Tasmanian devils (Sarcophilus harrisii).
    Cope HR; Peck S; Hobbs R; Keeley T; Izzard S; Yeen-Yap W; White PJ; Hogg CJ; Herbert CA
    Reprod Fertil Dev; 2019 Aug; 31(9):1473-1485. PubMed ID: 31046901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of deslorelin implants on reproduction and feeding behavior in Tasmanian devils (Sarcophilus harrisii) housed in free-range enclosures.
    Cope HR; Hogg CJ; Fagg K; Barnard O; White PJ; Herbert CA
    Theriogenology; 2018 Feb; 107():134-141. PubMed ID: 29149677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASSESSING THE EFFICACY OF DESLORELIN ACETATE IMPLANTS (SUPRELORIN) IN ALTERNATIVE PLACEMENT SITES.
    Cowl VB; Walker SL; Rambaud YF
    J Zoo Wildl Med; 2018 Mar; 49(1):1-8. PubMed ID: 29517451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception within an elasmobranch captive breeding programme: a case report on the eagle ray Aetobatus ocellatus using gonadotrophin-releasing hormone (GnRH) agonist deslorelin (Suprelorin).
    Janse M; Luten HA
    J Fish Biol; 2019 Jan; 94(1):196-199. PubMed ID: 30565692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of deslorelin implants on reproduction in the common brushtail possum (Trichosurus vulpecula).
    Eymann J; Herbert CA; Thomson BP; Trigg TE; Cooper DW; Eckery DC
    Reprod Fertil Dev; 2007; 19(8):899-909. PubMed ID: 18076822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable duration of reproductive suppression in male coyotes (Canis latrans) treated with a high dose of the gonadotrophin-releasing hormone agonist deslorelin.
    MacGregor MJ; Asa CS; Skinner DC
    Reprod Fertil Dev; 2017 Jul; 29(7):1271-1279. PubMed ID: 27161891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for selective contraception of individuals in conservation.
    Cope HR; Hogg CJ; White PJ; Herbert CA
    Conserv Biol; 2018 Jun; 32(3):546-558. PubMed ID: 29080297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of deslorelin (GnRH agonist) in companion animals: a review.
    Lucas X
    Reprod Domest Anim; 2014 Oct; 49 Suppl 4():64-71. PubMed ID: 25277434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary findings of fecal gonadal hormone concentrations in six captive sea otters (Enhydra lutris) after deslorelin implantation.
    Larson S; Belting T; Rifenbury K; Fisher G; Boutelle SM
    Zoo Biol; 2013; 32(3):307-15. PubMed ID: 22753108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DESLORELIN (SUPRELORIN
    Agnew MK; Asa CS; Franklin AD; McDonald MM; Cowl VB
    J Zoo Wildl Med; 2021 Jun; 52(2):427-436. PubMed ID: 34130384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZA Wildlife Contraception Center programme for wild felids and canids.
    Asa C; Boutelle S; Bauman K
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():377-80. PubMed ID: 23279543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term contraception in a small implant: A review of Suprelorin (deslorelin) studies in cats.
    Fontaine C
    J Feline Med Surg; 2015 Sep; 17(9):766-71. PubMed ID: 26323800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive effect and potential side-effects of deslorelin acetate implants in rats (Rattus norvegicus): preliminary observations.
    Grosset C; Peters S; Peron F; Figuéra J; Navarro C
    Can J Vet Res; 2012 Jul; 76(3):209-14. PubMed ID: 23277700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of GnRH agonist implants in oestrous induction and oestrous suppression in bitches and queens.
    Maenhoudt C; Santos NR; Fontaine E; Mir F; Reynaud K; Navarro C; Fontbonne A
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():393-7. PubMed ID: 23279547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii).
    Wait LF; Fox S; Peck S; Power ML
    PLoS One; 2017; 12(4):e0174994. PubMed ID: 28423030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High blood lead concentrations in captive Tasmanian devils (Sarcophilus harrisii): a threat to the conservation of the species?
    Hivert LG; Clarke JR; Peck SJ; Lawrence C; Brown WE; Huxtable SJ; Schaap D; Pemberton D; Grueber CE
    Aust Vet J; 2018 Nov; 96(11):442-449. PubMed ID: 30370598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonality and breeding success of captive and wild Tasmanian devils (Sarcophilus harrisii).
    Keeley T; Russell T; Carmody K; Kirk G; Eastley T; Britt-Lewis A; Post M; Burridge M; Eccleston S; Faulkner T; Forge T; Leonard J; Hughes RL
    Theriogenology; 2017 Jun; 95():33-41. PubMed ID: 28460677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pedigree analysis reveals a generational decline in reproductive success of captive Tasmanian devil (Sarcophilus harrisii): implications for captive management of threatened species.
    Farquharson KA; Hogg CJ; Grueber CE
    J Hered; 2017 Jul; 108(5):488-495. PubMed ID: 28379457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary and testicular endocrine responses to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants.
    Junaidi A; Williamson PE; Martin GB; Stanton PG; Blackberry MA; Cummins JM; Trigg TE
    Reprod Fertil Dev; 2007; 19(8):891-8. PubMed ID: 18076821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic and serum biochemical reference intervals for wild Tasmanian devils (Sarcophilus harrisii).
    Peck S; Corkrey R; Hamede R; Jones M; Canfield P
    Vet Clin Pathol; 2015 Dec; 44(4):519-29. PubMed ID: 26613213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.